Results 221 to 230 of about 25,737 (250)

Safe administration of venetoclax-obinutuzumab in a chronic lymphocytic leukemia patient with Brugada syndrome. [PDF]

Ann Hematol
Cardinali V, Coiro S, Martelli MP, Sportoletti P.   +3 more
europepmc   +1 more source

A case report on the safety and efficacy of aripiprazole for depression in Brugada syndrome. [PDF]

Ment Health Clin
Fahmy M, Bessada Y, Ramsey C, Zigun JR.
europepmc   +1 more source

Extravascular implantable cardioverter-defibrillator implantation in a teenager with Brugada syndrome and recurrent inappropriate shocks of subcutaneous implantable cardioverter-defibrillator. [PDF]

HeartRhythm Case Rep
Garibaldi S, Aimo A, Concistrè G, Nesti M, Panchetti L, Startari U, Mirizzi G, Santoro G, Piacenti M, Rossi A.   +9 more
europepmc   +1 more source

Clinical Features of Brugada Syndrome Patients With SCN5A Variants. [PDF]

J Cardiovasc Electrophysiol
Okamura S, Ochi H, Nakashima M, Akiyama R, Tokuyama T, Okubo Y, Miyauchi S, Miyamoto S, Oguri N, Uotani Y, Sakai T, Furutani M, Kihara Y, Nakano Y.   +13 more
europepmc   +1 more source

Correction to: SCN5A variant type-dependent risk prediction in Brugada syndrome. [PDF]

Europace
europepmc   +1 more source

[Brugada's syndrome].

Gaceta medica de Mexico, 2001
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Brugada syndrome

The Lancet, 2002
Brugada syndrome is characterized by an ECG pattern of right bundle branch block and ST-segment elevation in right precordial leads, and sudden death caused by ventricular fibrillation(VF). The cellular basis for the syndrome is thought to be due to an outward shift in the ionic current active during phase 1 of the right ventricular epicardial action ...
S R, Vavricka, A, Himmelmann, A, Schaffner   +2 more
openaire   +4 more sources